Magnetic Therapy Products News
- Wednesday's community calendar Tuesday, July 19, 2011 @ 11:35PMJULY 20 Story Time 2-3 p.m. July 20 and 27, Roundhouse Railroad Museum, 601 W. Harris St. Join Miss Rebecca for stories themed to the season, hands-on art projects and singing. Cost: $4 per child with regular adult admission For information, call 912-651-6823, ext. 3, or go to chsgeorgia.org. “Pack the Park” 7 p.m. July 20, Grayson Stadium, 1401 E. Victory Drive. Interfaith Hospitality of ...
- Roche signs agreement to acquire mtm laboratories Tuesday, July 19, 2011 @ 1:39AMVentana Medical Systems, Inc., a member of the Roche Group, announced today that Roche has signed an agreement under which it will acquire 100 percent of mtm laboratories AG (mtm), a privately-held company based in Heidelberg, Germany.
- Competitive Technologies to Sell BiCOM's Medical Devices Friday, July 15, 2011 @ 10:56AMCompetitive Technologies to Sell BiCOM''s Medical Devices Competitive Technologies, Inc. 15.07.2011 17:39 ------------------------------------------------------------------
- DGAP-News: Competitive Technologies to Sell BiCOM´s Medical Devices (deutsch) Friday, July 15, 2011 @ 10:54AMCompetitive Technologies to Sell BiCOM´s Medical Devices Competitive Technologies, Inc. 15.07.2011 17:39 FAIRFIELD, Conn., 2011-07-15 17:39 CEST (GLOBE NEWSWIRE) …
- Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada™ (*)) in Multiple Sclerosis Monday, July 11, 2011 @ 12:57AMPARIS--(BUSINESS WIRE)--Genzyme announced today positive top-line results from CARE-MS I.
- Amgen files sBLA for XGEVA with FDA to treat castrate-resistant prostate cancer Tuesday, June 28, 2011 @ 1:35AMAmgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.
- Press Release Tuesday, June 14, 2011 @ 8:03AMInternational Stem Cell Corporation (OTCBB:ISCOE) announces the discovery of a novel, patent-pending technology to produce unlimited numbers of liver cells (hepatocytes) that are free of contamination with potentially dangerous undifferentiated cells.
- BDCC hands out prize money to area businesses Thursday, June 9, 2011 @ 3:36PMBRATTLEBORO -- More than $67,000 in prize money was handed out to new and expanding businesses in Windham County at the annual Brattleboro Development Credit Corporation business plan competition.
- Elbit Imaging Announces Availability of its Annual Report on Form 20-F Through its Website Pursuant to Nasdaq Listing ... Thursday, June 9, 2011 @ 3:38AMElbit Imaging Ltd. , today announced that its annual report on Form 20-F for the year ended December 31, 2010, as filed with the U.S. Securities and Exchange Commission on June 6, 2011 is available through its website at: http://www.elbitimaging.com under: "Investor Relations - Financial Reports - 2010 - 20F/Form 2010."
- LLS announces four new Academic Concierge partnerships for cancer drug development Tuesday, June 7, 2011 @ 7:30AMWith more than 320 academic science research grants currently in its portfolio, The Leukemia & Lymphoma Society (LLS) has made it a priority to help move promising discoveries more quickly from the laboratory to clinical trial and to patients with cancer.
- Medizintechnik Purchases BSD Medical's BSD-2000/3D/MR Hyperthermia System Monday, June 6, 2011 @ 8:13AMSALT LAKE CITY--(BUSINESS WIRE)--BSD Medical announced that Dr. Sennewald Medizintechnik purchased a BSD-2000/3D/MR Hyperthermia System, which is the integration of a regional hyperthermia system with a Siemens MR Imaging System.
- Elbit Imaging Ltd. Board of Directors Resolves not to Distribute Dividends in Upcoming Year Monday, June 6, 2011 @ 3:06AMElbit Imaging Ltd. announced today that the Board of Directors of Elbit has resolved not to distribute any dividends for at least the next 12 months. At the end of the abovementioned 12-month period the Board of Directors will evaluate whether to extend such policy.
- Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets Wednesday, June 1, 2011 @ 6:42AMNEW YORK , June 1, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue: Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets http://www.reportlinker.com/p0298005/Medical-Magnetic-Resonance-Imaging-MRI-Technologies-and-Global-Markets.html?utm_source=prnewswire&utm_medium=pr&utm_campaign ...
- Elbit Imaging ltd. Terminates Standby Equity Purchase Agreement With Yorkville Tuesday, May 31, 2011 @ 6:17PMTEL AVIV, Israel , May 31, 2011 /PRNewswire-FirstCall/ -- Elbit Imaging Ltd. (NASDAQ: EMITF) ("Elbit") announced today that the Standby Equity Purchase Agreement dated March 25, 2011 between Elbit and YA Global Master SPV Ltd. ("Yorkville") was terminated by mutual consent. Elbit did not draw down any funds or issue any shares under the agreement. For further information with respect to these ...
- Elbit Imaging Ltd. Announces Results for First Quarter Results of 2011 Tuesday, May 31, 2011 @ 1:52PMElbit Imaging Ltd. announced today its results for the first quarter of 2011.
- Reportlinker Adds the Future of In Vitro and In Vivo Diagnostic Integration Tuesday, May 31, 2011 @ 5:15AMReportlinker.com announces that a new market research report is available in its catalogue:
- Jenoptik's Lasers & Material Processing Division With New Products At LASER In Munich Monday, May 23, 2011 @ 12:10AMThe Lasers & Material Processing division of Jenoptik will have the more powerful version of the green disk laser type JenLas D2.mini, a femtosecond laser for industrial applications and a new infrared disk laser for micro materials processing on display at the LASER World of PHOTONICS from May 23-26, 2011.
- Queen offers 'sympathy' over Irish frictions Thursday, May 19, 2011 @ 12:27AMDUBLIN - Queen Elizabeth II made a powerful statement Wednesday night expressing "deep sympathy" to all who had suffered as a result of the troubled relations between England and Ireland.
- Philips Launches Therapy Centers Tuesday, May 10, 2011 @ 3:10PMRoyal Philips Electronics and IBA Group have agreed to create patient-centric proton therapy centers.
- IBt Bebig presents its new HDRplus 3.0 at ESTRO Tuesday, May 10, 2011 @ 11:01AMIBt Bebig presents its new HDRplusTM 3.0 at ESTROMay 10, 2011Seneffe - Belgium, May 10, 2011, IBt Bebig (Reuters: IBTH.BR - Bloomberg: IBTB BB) has announced today that it releases its new version of the treatment planning HDRplusTM 3.0 at the …
- Given Imaging Announces New Clinical Studies Recommend Increased Use of High Resolution Manometry to Diagnose Motility ... Tuesday, May 10, 2011 @ 9:03AMPodium Presentation Suggests ManoScan(TM) High Resolution Manometry Is an Important Tool for Determining Treatment Efficacy
- iCAD Reports First Quarter Financial Results Tuesday, May 3, 2011 @ 4:28PMNASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, today reported financial results for the first quarter of fiscal year 2011. Total revenue for the three months ended March 31, 2011, was $7.3 million, compared to $6.5 million in the ...
- Reportlinker Adds Gastrointestinal Stromal Tumors (GIST) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Thursday, April 14, 2011 @ 5:32AMReportlinker.com announces that a new market research report is available in its catalogue:
- iCAD Granted U.S. Patent on MRI Image Analysis Solutions Tuesday, April 12, 2011 @ 8:43AMNASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces that the United States Patent and Trademark Office recently granted the company Patent Number 7,903,853. This patent covers iCAD’s sophisticated magnetic resonance imaging (MRI ...
- iCAD Granted U.S. Patent on MRI Image Analysis Solutions Tuesday, April 12, 2011 @ 8:30AMiCAD, Inc. , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces that the United States Patent and Trademark Office recently granted the company Patent Number 7,903,853.
- Novartis Therapy Gilenya Reduced the Risk of MS Disability Progression Regardless of Treatment History or Disease ... Monday, April 11, 2011 @ 12:30AMA new analysis demonstrated that Gilenya⢠reduced the risk of disability progression in patients with relapsing-remitting multiple sclerosis , regardless of treatment history. This analysis of the phase III two-year FREEDOMS study is one of 11 abstracts on Gilenya being presented at the 63rd annual meeting of the American Academy of Neurology .
- Novartis therapy GilenyaTM reduced the risk of MS disability progression regardless of treatment history or disease ... Monday, April 11, 2011 @ 12:16AMNovartis International AG / Novartis therapy GilenyaTM reduced the risk of MS disability progression regardless of treatment history or disease severity, new analysis shows . Processed and transmitted by Thomson Reuters ONE. The issuer is solely …
- T2 Biosystems Demonstrates First-Ever Ability to Accurately and Rapidly Detect Systemic Candida Infection Directly in ... Thursday, April 7, 2011 @ 7:13AMLEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, Inc., a company developing next-generation diagnostic products, presented data on the rapid detection of the fungal infection Candida at the Annual Meeting of the Mycoses Study Group.
- ‘Banking’ on the natural healthcare market Sunday, April 3, 2011 @ 9:58PMKUCHING: For Bumiputera entrepreneur Zaina Anas, total well-being would mean having one’s health at its optimal level.
- Sunday business spotlight: The Center for Mind, Body & Spirit Saturday, April 2, 2011 @ 11:16PMProducts/services offered: Therapeutic massage, Reiki, EFT, magnetic therapy and Nikken products, sound healing, biofeedback, detox foot bath, cleanse coaching, nutritional education, intuitive card readings, chakra balancing, energy healing, specialized wedding ceremonies.
- Reportlinker Adds Medical Imaging Markets Thursday, March 31, 2011 @ 8:24AMReportlinker.com announces that a new market research report is available in its catalogue:
- Alnylam Completes Enrollment in ALN-VSP Phase I Clinical Trial Thursday, March 31, 2011 @ 7:19AMCAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it has completed enrollment in its ALN-VSP Phase I multi-center, multinational, open label, dose escalation clinical trial. The study’s objectives were to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics in patients with advanced solid ...
- Alnylam Completes Enrollment in ALN-VSP Phase I Clinical Trial Thursday, March 31, 2011 @ 7:00AMAlnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today announced that it has completed enrollment in its ALN-VSP Phase I multi-center, multinational, open label, dose escalation clinical trial.
- Glencore Grain Buys Mendenhall Warehouse Wednesday, March 30, 2011 @ 4:10PMGlencore Grain USA LLC, a Stamford, Conn.-based affiliate of Swiss commodities giant Glencore International AG, has paid $6 million for the warehouse ...
- Rusty Hyneman Files Chapter 7 Bankruptcy Wednesday, March 30, 2011 @ 4:10PMMemphis real estate developer William “Rusty” Hyneman filed a Chapter 7 bankruptcy petition Tuesday in U.S. Bankruptcy Court for West Tenn...
- Trenary to Earn $1.7M as Pinnacle Consultant Wednesday, March 30, 2011 @ 4:10PMFormer Pinnacle Airlines Corp. president and CEO Phil Trenary will be paid a consulting fee of $1,682,440 for the two years that he serves as a consul...
- Chamber Takes Trip to NYC for Media Tour Wednesday, March 30, 2011 @ 4:10PMRepresentatives from the Greater Memphis Chamber, the Memphis Convention and Visitors Bureau and Mayor A C Wharton Jr.’s office visited New York...
- Fusion IP PLC - Half Yearly Report Wednesday, March 30, 2011 @ 2:05AMFusion IP PLC - Half Yearly Report
- Reportlinker Adds Molecular Diagnostics Markets Tuesday, March 29, 2011 @ 5:27AMReportlinker.com announces that a new market research report is available in its catalogue:
- Elbit Imaging Ltd. Announces Results for the Year 2010 Tuesday, March 29, 2011 @ 5:09AMElbit Imaging Ltd. announced today its results for the year 2010.
- Reportlinker Adds Global Nanobiotechnology Industry Monday, March 21, 2011 @ 11:58AMReportlinker.com announces that a new market research report is available in its catalogue:
- Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment for use in ... Monday, March 21, 2011 @ 1:30AMNovartis International AG / Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment for use in the EU Processed and transmitted by Thomson Reuters. The issuer is solely responsible for the content …
- Annual Congress of European Association of Urology opens in Vienna Saturday, March 19, 2011 @ 3:02AMThe 26th Annual Congress of the European Association of Urology (2011 EAU congress) kicked off on Friday at the Vienna Austria Center in the Austrian capital Vienna.
- Elbit Imaging Announces an Off-Market Take Over Bid by its Indirect Subsidiary for EDT Shares Thursday, March 10, 2011 @ 4:02AMElbit Imaging Ltd. announced today that its indirect subsidiary, EPN Investment Management LLC, has announced an off-market takeover bid by EPN GP LLC or an entity affiliated with it to acquire all of the outstanding units of EDT Retail Trust that EPN affiliates do not already own .
- Elbit Imaging Announces Results of "Dutch Auction" to Institutional Investors for its Debenture Offering in Israel Wednesday, March 9, 2011 @ 5:05PMTEL AVIV, Israel , March 9, 2011 /PRNewswire-FirstCall/ -- Elbit Imaging Ltd. (NASDAQ: EMITF) ("Elbit") announced today that the offering by way of "Dutch Auction" to institutional investors in connection with a proposed public offering in Israel by way of extending its existing Series D Debentures, pursuant to the shelf prospectus filed on July 21, 2009 , has concluded. Elbit is offering up to ...
- Elbit Imaging Announces Results of "Dutch Auction" to Institutional Investors for its Debenture Offering in Israel Wednesday, March 9, 2011 @ 12:38PMElbit Imaging Ltd. announced today that the offering by way of "Dutch Auction" to institutional investors in connection with a proposed public offering in Israel by way of extending its existing Series D Debentures, pursuant to the shelf prospectus filed on July 21, 2009, has concluded.
- Hologic Showcases Its 3D Mammography (Breast Tomosynthesis) At National Consortium Of Breast Centers (NCBC) Meeting Saturday, March 5, 2011 @ 5:33AMHologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will showcase its 3D mammography and other new, ready-to-market technologies in women's imaging at the 21st Annual National Interdisciplinary Breast Center ...
- Philips Shows New Approach and Advances in Clinical Collaboration at European Congress of Radiology 2011, to Drive ... Friday, March 4, 2011 @ 3:17PMVIENNA , March 4, 2011 /PRNewswire-FirstCall/ -- - Philips' Imaging 2.0 Concept Brings Together a Host of New Technology Introductions and Greater Partnership With Radiologists in Mind At the European Congress of Radiology (ECR) 2011, Royal Philips Electronics (NYSE: PHG, AEX: PHI) is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology ...
- ICAP Ocean Tomo Announces Four Patent Sets From Oxford Instruments - Each Represents an Important Advancement in ... Friday, March 4, 2011 @ 3:17PMCHICAGO, March 4, 2011 /PRNewswire/ -- The Oxford Instruments patents will be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March 31, 2011 in New York City. Oxford Instruments has determined that these patents are not strategic for its ongoing business. The lots include: a concept for the use of magnetic particles for targeted cancer treatment, advanced sterilization ...
- Philips Shows New Approach and Advances in Clinical Collaboration at European Congress of Radiology 2011, to Drive ... Friday, March 4, 2011 @ 10:31AMVIENNA, March 4, 2011 /PRNewswire/ At the European Congress of Radiology (ECR) 2011, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and …